Design Therapeutics (DSGN) Q4 2022 Earnings

14MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.34
-0.3
-0.26
-0.22

Details

Expected EPS
-0.34
Actual EPS
-0.31
Surprise EPS
0.03
Surprise Percent
+8.82%

Description

Design Therapeutics (DSGN) has reported earnings of -0.31 per share for Q4 2022.

0 Comments

Share your thoughts